Process for the enantiospecific synthesis of intermediates for hexahydro-benzo¬d naphtho ¬2,1-b azepines
CA 1325226 C · Owner: Schering Corporation · Inventors: Berger, Joel G.; Clader, John W.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Biologically active, enantiomerically substantially pure intermediates of trans-hexahydro-benzo?naphtho2,1-b azepines are prepared. The present invention involves a process for preparing compounds of the general formula 3:, wherein: R?is , ;, Each R1 is independently H or alkyl; Q is methylene, -O- or-S-;, m and n are independently variable and may each have a value of 0, 1 or 2, with the provisos that the sum of m and n is not greater than 3 that m, may not equal zero when Q is -O- or -Sand that when Q is -CH2-, m and n, cannot both be zero; X is hydrogen, halo, alkyl, alkylthio, alkylsulfinyl alkylsufonyl, hydroxy, alkoxy or trifluoromethyl; Y is hydrogen, hydroxy, alkoxy, -OC(O)NR2R3 …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted December 14, 1993. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended December 14, 2010.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.